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Abstract: Purpose: To measure the release of an antibiotic mixture of ciprofloxacin, cerfuroxim and metronidazole  
(TreVitaMix, TVM) through human dentine and to assess the growth inhibition of Fusobacterium nucleatum.  
Material and Methods: Twenty-four extracted human incisors were scaled and endodontically treated. Root canals were 
either filled with antibiotic tri-mixture (TVM) or with the carrier material alone (propylene glycol, PG) and were coron-
ally and apically sealed with a flowable composite. Transradicular medicament release was spectrophotometrically meas-
ured at 277 nm in simulated body fluid for up to 21 days. In a second part, an agar diffusion assay (F. nucleatum) with 
representative TVM concentrations as determined in the first part was performed to study the growth inhibition. Samples 
were anaerobical incubated for 48 h and inhibition zones were measured. Results: TVM was spectrophotometrically de-
tectable in the immersion solution and released in decreasing concentrations up to 21 days (222.5 ± 65.2 μg/ml at day 1 
and 35.1 ± 15.6 μg/ml at day 21). In addition, inhibition zones were shown in the agar diffusion assay at representative 
TVM concentrations. The carrier material showed no antibacterial effect. Conlusion: TVM showed the potential to pene-
trate through dentine and to inhibit bacterial growth. Therefore, it might have the potential to disinfect the outer root sur-
face in perio-endo lesions, but further research is needed to confirm these observations. 
Keywords: Agar diffusion, bacteria, dentine, perio-endo lesion, TreVitaMix. 
1. INTRODUCTION 
Endodontic and periodontal diseases are primarily caused 
by bacterial infections [1-5] and studies suggest that infected 
root canal systems and periodontal pockets have analogical 
bacterial species [2, 4-8]. Untreated infections in one of these 
compartments can lead to symptoms or signs of disease ini-
tiation and progression inside the other tissues [6, 7, 9, 10]. 
This can occur biderectionally, for example from the perio-
dontium to the root canal and vice versa. Potential communi-
cation pathways in the roots are accessory canals, canal 
ramifications, dentinal tubules, deltas of the apical part, fins 
and anastomoses. Therefore, bacteria can survive not only in 
the root canal itself but also inside these distinctive anatomi-
cal structures [11]. Typically, in periodontal pockets more 
bacteria species can be found than in infected root canal sys-
tems but there is also a more complex microflora in con-
taminated root canals of teeth that have a coexisting perio-
dontal and endodontic disease in comparison with teeth that 
have a sole periapical pathosis [4]. 
The treatment of such infections is challenging and some 
debate still exists as to which problem should be treated first, 
especially in combined lesions [12]. However, the root canal 
might be considered as an ideal space for the placement of a  
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medicament to disinfect the pathologically altered periodon-
tal tissues as well due to their anatomical proximity in cases 
with necrotic pulp tissue or and insufficient root canal treat-
ment. Thus, antibacterial endodontic drugs may represent a 
way to eradicate periodontal infection during root canal 
treatment as well, especially when using disinfecting agents 
applied as inter-appointment dressings in combined lesions, 
which can diffuse through the dental hard tissues. Desirably, 
this would lead to an adequate antibacterial concentration 
that purge the pathogens in a predictable manner at the root 
surface [13, 14].  
Hoshino and co-workers found out that a combination of 
ciprofloxacin, metronidazole and minocycline has the ability 
to disinfect contaminated root dentine in vitro [15]. Sato and 
co-workers found that this combination was also adequate 
for disinfection of contaminated root dentine in situ [16]. 
Especially metronidazole showed the ability to penetrate 
through dentine [17].  
A similar triple antibiotic mixture consisting of cipro-
floxacin, cerfuroxim and metronidazole (TVM) (TreVi-
taMix, MedCem GmbH, Weinfelden, Switzerland) was fur-
ther developed, which was then mainly used for revasculari-
sation in pediatric dentistry [18-24]. Such medications, how-
ever, could be an alternative way to sustainably reach patho-
genic bacteria of the periodontium provided that an adequate 
permeation through the dentine system is achieved by lead-
ing to a prolonged endodontic-periodontal infection control. 
However, the specific application of intracanal dressings as 
an alternative administration route to treat periodontitis is not 
well investigated yet. Therefore, this study aimed to assess a 
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commercially available mixture of three antibiotics (TVM) 
and their ability to penetrate through human dentine to in-
hibit bacterial growth, exemplarily evaluated using Fusobac-
terium nucleatum (F. nucleatum). 
The hypotheses were:  
I)  TVM has the ability to penetrate through dentine for up 
to 21 days  
II)  The determined concentrations inhibit the bacterial 
growth  
2. MATERIAL AND METHODS 
This investigation was divided in two parts: in the first 
part of the study, the concentrations of TVM release from 
medicated root canals were spectrophotometrically assessed 
in simulated bodyfluid (SBF) after a cumulative storage time 
of three weeks. In the second part, representative concentra-
tions as obtained from the first study were screened for their 
potential to inhibit bacterial growth using an agar diffusion 
test. In addition, the minimally inhibitory concentration 
(MIC) and the minimum bactericidal concentration (MBC) 
of TVM were determined. 
2.1. Medicament Release Through Human Dentine 
Twenty-four extracted human incisors with only one root 
canal were used from the department’s collection of human 
teeth. The extracted teeth used in this study were collected 
before the study during normal therapy as anonymous by-
products and kept in tap water. According to that, our Medi-
cal Ethical Board determined that the conducted research 
was not covered by the regulations of the “Act on Medical 
Research Involving Human Subjects” (METc 2009.305). 
Therefore it was not necessary to have a written informed 
consent. Before treatment, patients were elucidated about 
general research aim and agreed verbally. For anonymous 
reasons this was not documented. The crowns were removed 
2 mm below cement-enamel junction using a handpiece 
(KaVo, Biberach, Germany) and a cylindrical diamond bur 
(Intensiv, Grancia, Switzerland) under continuous water-
cooling. Teeth were then endodontically treated as follows: 
the coronal third was widenend with crown down sequence 
of Gates Glidden drills size 3 – 2 – 1 (Dentsply, Ballaigues, 
Switzerland). The working length was measured with a ISO 
10 K-File (Dentsply) by inserting the instrument into the root 
until the tip was just observable beyond the apical foramen. 
The working length was defined by subtracting 1 mm of the 
measured length. To prevent contamination of the root sur-
face with endodontic irrigants during root canal treatment, 
the apical part of the root was sealed with a flowable com-
posite (Tetric Flow Evo, Ivoclar Vivadent, Schaan, Liechten-
stein) and rubber dam was applied to the coronal aspect of 
the root. The root canals were shaped using ProTaper
®
 Uni-
versal instruments up to F3 (Dentsply). The root canals were 
rinsed with 1 ml of a 1% NaOCl solution (Hedinger, Stutt-
gart, Germany) after each instrument [25]. Irrigation was 
performed with a 30-gauge irrigating needle 1 mm shorter as 
working length (Hawe Neos, Bioggio, Switzerland). In total, 
the root canals were irrigated cumulatively for 25 min with 
NaOCl followed by a final flush of 5 ml of 17% EDTA 
(Kantonsapotheke Zürich, Zürich, Switzerland) for 5 minutes 
to remove the smearlayer. Finally, the canals were rinsed 
with 10 ml 0.9% sterile saline (NaCl, Braun Melsungen, 
Melsungen, Germany) to remove the EDTA. Thereafter, 
teeth were cut coronally to a final root length of 10 mm. The 
flowable composite was chipped away using a scaler and the 
apical seal was renewed with the dentine bonding agent Syn-
tac-Classic (primer & adhesive, Ivoclar Vivadent) and He-
liobond (Ivoclar Vivadent) according to the manufacturers 
instruction. The bonding agent was light cured for 40 s using 
a LED device (mode: HIP, 1200 mW/cm2, Bluephase, Ivo-
clar Vivadent) and the apical part was freshly covered with a 
flowable composite (Tetric Flow Evo, Ivoclar Vivadent) and 
light cured again for 10 s (Bluephase).  
For the next 24 h, the teeth were stored at room tempera-
ture in distilled water and stratified after spectrophotometric 
evaluation of the blank of each tooth using a spectropho-
tometer (Spectra Max M2, Bucher Biotec AG, Basel, Swit-
zerland) at a wavelength of 277 nm. After drying of the ca-
nals with paper points (Orbis Dental, Münster, Germany), 
twelve roots were filled with TVM (test group; n=12) using a 
lentulo (size 3, Dentsply). The remaing roots were filled with 
the TVM carrier material (propylene glycol added with mac-
rogolum unguentum; PG) in the same way (negative control; 
n=12). Thereafter, the coronal part was cleaned carefully 
with foam pellets (Pele Tim, Voco, Cuxhaven, Germany) 
and 0.9% sterile saline and sealed with Syntac-Classic (Ivo-
clar Vivadent) and Tetric Evo Flow (Ivoclar Vivadent) as 
described for renewal of the apical seal. The teeth were then 
immersed in 2 ml of SBF [26] and the solutions were meas-
ured using a special UV cuvette (Nr. 2722120, Portmann 
Instruments, Biel-Benken, Switzerland) by UV spectroscopy 
(Spectra Max M2) after 1, 3, 5, 7, 11, 14 and 21 days at 200 
– 400 nm. SBF was replaced with fresh solution after each 
measurement. Quantitative analysis of TVM was analysed 
using UV-spectroscopy at 277 nm. The release of TVM was 
measured in μm/ml after 1, 3, 5, 7, 11, 14 and 21 days.  
2.2. Leakage Test 
To exclude potential leakage of TVM through the roots, 
teeth were exposed to dye penetration after the medicament 
releasing test. For this purpose roots were covered with nail 
varnish (Malva, Geneva, Switzerland), embedded in epoxy 
resin (Paladur, Heraues Kulzer, Hanau, Germany) and sub-
sequently placed for 20 h into a 0.5% fuchsin-solution 
(Fluka, Buchs, Switzerland). Following, the roots were cut 
longitudinally with a diamond saw (Isomet 1000, Buehler 
Ltd., Lake Bluff, IL, USA) under kerosene cooling (Fluka) 
and fuchsin penetration was assessed using a light-
microscope (Tessovar, Carl Zeiss, Feldbach, Switzerland).  
Normal distribution was tested with Kolmogorov-
Smirnov-Test. Differences between time measurements and 
groups were tested by one-way analysis of variance 
(ANOVA) and Scheffé post-hoc test (p < 0.05). Addition-
ally, for each group separately paired t-test were used to in-
vestigate differences between individual time-points (p < 
0.05). All analysis were performed using a commercially 
available statistical software (StatView Version 5, Abacus 
Concepts Inc., Berkley, CA, USA). 
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2.3. Agar Diffusion Test 
To study the antibacterial effects of TVM, aqueous solu-
tions with concentrations corresponding to the results from 
part I of this study were prepared and tested on Fusobacte-
rium nucleatum subsp. nucleatum (OMZ-Nr. 598).  
For this purpose, petri dishes (Sterilin Limited, Newport, 
UK) were prepared by mixing 20 ml of Fastidious Anaerobe 
Agar (acumedia
®
, NEOGEN
®
 Corporation, Michigan, USA) 
(FAA-Agar), which was autoclaved (121°C, 20 min, 1.2 bar) 
with 1 ml of the corresponding F. nucleatum inoculum under 
a laminar flow clean bench (SKAN EVZ 120, SKAN AG, 
Allschwil, Switzerland). Wells measuring 5 mm in diameter 
were punched out after solidification of the inoculated agar. 
Afterwards, wells were filled with solutions of different 
TVM concentrations (200-, 100-, 40-, 20-, 10- μg/ml), PG as 
carrier material, chlorhexidine (0.2%) and SBF alone were 
used as control media. These concentrations correlated with 
those obtained from part I of the study. After 48 h of anaero-
bic incubation (Microincubator MI22NK, Scholzen Microbi-
ology Systems AG, Necker, Switzerland) at 37 °C with 5% 
CO2, 10% H2, and 85% N2. The experiments were performed 
in triplicates.  
The minimal radius of the inhibition zone was measured 
in mm from the external punch diameter and the area in mm
2 
calculated using standardized photographs (Nikon D90, 
Nikon Coorporation, Tokyo, Japan). All images were cali-
brated and analysed with a special measuring software (Im-
ageJ 1.42q, Wayne Rasband, National Institutes of Health, 
USA). The area in mm
2
 of the outer and inner countour was 
measured and the difference calculated. Data were descrip-
tively presented. 
2.4. MIC/MBC  
In addition, MIC and MBC were determined using liquid 
cultures in 96-well flat-bottom polystyrene microtitre test 
plates [27] (Nunclon Delta, Intermed, Denmark). A shematic 
outline of the experiment of the test plate is outlined in Fig. 
(3). Different TVM concentrations (10, 7.5, 5.0, 4.0, 3.0, 2.0, 
1.5, 1.0, 0.5, 0.25, 0.12 and 0 μg/ml = SBF only) were tested 
again on F. nucleatum control wells containing 170 μl of 
modified fluid universal medium (mFUM) [28] (100% 
growth controls) and the test wells 150 μl + 30 μl of TVM. 
Plates were covered with plastic lids and pre reduced for 45 
min at 37°C in an anaerobic glove box (Microincubator 
MI22NK) and following inoculated with 20 μl of F. nuclea-
tum culture, which was adjusted to an optical density at 550 
nm of OD550nm = 0.5 ± 0.05 (Spectrophotometer U-2000, 
HITACHI, Tokyo, Japan). After 48 h of anaerobical incuba-
tion at 37°C (Microincubator MI22NK) each plate was cov-
ered with a plastic foil (Plate Sealer, R&D Systems, Inc., 
Minneapolis, USA) and vigorously shaken for 10 seconds 
(model AM 69 micro-shaker, Dynatech Produkte AG, 
Kloten, Switzerland) and immediately scanned (492 nm) 
with a spectrophotometer (Epoch Micrplate Spectropho-
tometer, BioTek, Luzern, Switzerland). MIC was defined as 
the minimal TVM concentration that prevent visible growth. 
For MBC, the corresponding TVM concentrations of 
MIC testing were used, inoculated and aerobically incubated 
for 3 min, after which the plates were momentarily shaken 
and 25 μl of the TVM test wells withdrawn and stroked on 
Columbia Blood Agar plates (CBA) (Difco BD
®
 279240, 
DIFCO-BD - Sparks, MD, USA; Oxoid, Ltd., Basingstoke, 
Hamps, UK) and incubated anaerobically for 48 h at 37°C. 
Bacterial growing was visually analysed using a stereo-
microscope (Stemi 2000, Carl Zeiss, Feldbach, Switzerland). 
3. RESULTS  
3.1. Medicament Release Through Dentine 
The release rate of the antibiotic mix and the pure carrier 
material as a control (μg/ml) up to 21 days is depicted in Fig. 
(1). 
At baseline, no significant differences between test 
(TVM; 1.6 ± 0.34 μg/ml) and control group (PG; 1.5 ± 0.4 
μg/ml) was observed (p > 0.05).  
In the test group, all teeth filled with TVM showed a re-
lease up to day 21. From day 1 (222.5 ± 65.2 μg/ml) to day 
21 (35.1 ± 15.6 μg/ml), the TVM group showed a signifi-
cantly greater release at all measurement times as compared 
to the PG group (p < 0.01). No significant differences were 
observed in the PG group at different measurement intervals, 
whereas in the TVM group significant differences between 
day 1 and day 3 (p = 0.0003) and between day 3 and day 5 (p 
= 0.0001) were observed. 
The fuchsin penetration test showed no leakage at the oc-
cluding composite interface at all teeth. Thus, any leakage of 
the compound is presumed to occur through the root dentine 
walls and not through the adhesive closures. 
3.2. Agar Diffusion Test 
The minimal inhibition zones (mm
2
) for the different 
TVM concentrations after 48 h are presented in Fig. (2). The 
PG group showed no inhibition zones whereas 0.2% CHX 
(7.27 ± 0.27 mm) as well as TVM in all concentrations 
showed clear inhibition zones: However, the latter showed 
decreasing zones of inhibition with lower concentrations of 
the test material: 7.2 ± 1.0 mm at 200 μg/ml, 7.0 ± 0.3 mm at 
100 μg/ml, 3.4 ± 0.2 mm at 40 μg/ml, 2.6 ± 0.2 mm, 20 
μg/ml and 2.0 ± 0.2 mm at 10 μg/ml. 
3.3. MIC/MBC  
The minimal inhibitory concentration of TVM for F. nu-
cleatum (OMZ 598) was 0.13 μg/ml, the minimal bacteri-
cidal concentration accounted for > 10 μg/ml. 
4. DISCUSSION 
The purpose of this study was to evaluate the ability of a 
mixture of three antibiotics (TVM) to penetrate through root 
dentine and to assess the inhibition of the growth of Fuso-
bacterium nucleatum by an agar diffusion test with the rep-
resentative concentrations as obtained from the first part. In 
addition, MIC and MBC concentrations for that specific bac-
terium were assessed in order to rate the antibacterial poten-
tial accordingly. 
In the first evaluation, human teeth filled with TVM 
showed the highest release rate after 24 h, which decreased 
until day 21. However, after 21 days there was still a 
Intracanal Medication for Root Surface Disinfection The Open Dentistry Journal, 2015, Volume 9    399 
 
Fig. (1). Box- and whiskerplot of the release (μg/ml) of TreVitaMix (TVM) and propylene glycol (PG) up to 21 days. Release in μg/ml at 
baseline (unfilled teeth) and after day 1, 3, 5, 7, 11, 14 and 21 are presented for TVM and PG. Asterisks indicate significant differences be-
tween TVM- and PG-group for each measurement, bars indicate significant differences within groups between different time points. 
 
 
Fig. (2). Mean area of inhibition zones in mm
2
 and SD (in triplicates) after 48 h in the agar-diffusion-test with Fusobacterium nucleatum in-
oculated agar. 
 
 
Fig. (3). Experimental arrangement of the test plates for MIC / MBC determinations of Fusobacterium nucleatum. W.K.: growth controls; 
TEST: respective concentrations of medicament; BLANK: Only medium as control.  
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considerable release of TVM detectable. These results 
showed that TVM was able to penetrate through human den-
tine. These results are in accordance with the literature, 
where this effect was observed in vitro for metronidazole 
alone [17], CHX [29] and a triple antibiotice mixture of 
ciprofloxacin, metronidazole and minocycline [16]. How-
ever, Sato et al. showed this effect only up to 48 h, whereras 
in the present study the release was assessed up to 21 days. 
The carrier material propylene glycol PG was used in com-
bination with TVM to get a quicker medicament penetration 
[30]. With the leakage test performed, it was ensured that the 
penetration of the medicament was limited to the transden-
tinal pathway and not through the fillings at both ends as 
none of the samples showed fuchsine leakage.  
The concentrations at the different timepoints of Part I 
obtained from the TVM group were rounded and the bacte-
rial growth inhibiting potential was assessed in a simple agar 
diffusion assay using decreasing concentrations of 200, 100, 
40, 20 and 10 μg/ml, respectively. The results indicated that 
the minimal radius of inhibition zones was related to the 
TVM concentrations. However, also with smaller amounts of 
TVM, an inhibition zone was still detectable. This may not 
be surprising as the determined MIC and MBC concentra-
tions accounted for  10 g/ml, respectively. For the whole 
study, F. nucleatum was used due to the fact that is the major 
co-aggregation bridge organism linking early and late colo-
nizer [31]. Therefore it was considered being a good candi-
date for this screening study. However, only one bacterial 
strain was assessed and no complex biofilms were screened, 
which may be considered as a shortcoming of the present 
study. 
From a clinical perspective, penetration through different 
anatomical and morphological compartments should also be 
considered. Vasiliadis and co-workers showed that intratubu-
lar calcification was more pronounced at the mesial and dis-
tal root aspects than in the bucco-lingual counterparts [32]. 
Paqué et al. reported that dentine sclerosis was the most im-
portant factor affecting the permeability of root dentine [33]. 
It starts in the third decade of life and is a normal physio-
logical phenomenon in the apical part and progress coronally 
by the age. The degree of sclerosis might therefore has a 
great impact on dentine permeability. Further research on 
this topic is therefore also necessary because the incidence of 
periodontitis is greater with age. Additionally scaling and 
root planing as well as supportive periodontal therapy could 
also influence by the years the amount of sclerotic dentine. 
In general Ca(OH)2 is commonly used as intracanal me-
dicament and concomitant the most invesitaged [34]. How-
ever, it cannot relied that calcium hydroxide is able to elimi-
nate all pathogens in all cases – as shown by other studies 
[25, 35]. This common problem is associated for all single 
intracanal drugs and supports that the use of more than one 
medicament in contaminated teeth is necessary. This can be 
done by separate dressings or in combination of disinfec-
tants.  
The usage of non-toxic intracanal dressings is crucial to 
eliminate bacteria and to support tissue repair, preferably 
regeneration [36]. The use of a triple antibiotic medicament 
might help in eliminating bacteria but wide variability was 
found in periodontal pathogen antibiotic resistance patterns 
and should concern clinicians empirically in selecting antibi-
otic treatment regimens for chronic periodontitis patients 
[37-39]. On the other hand, a combination of antibiotics 
would maybe also decrease the likelihood of the develop-
ment of resistant bacterial strains [40]. Another previous 
problem of the use of antibiotics in particular tetracyclines 
were tooth discoloration [41]. The triple antibiotic medica-
ment TVM used in this study exchanged minocycline as me-
dicament by cefuroxime, which belongs to the class of the 
cephalosporine antibiotics and causes no discolorations [18].  
In general, the common antibiotic regime during perio-
dontal treatment is the combination of metronidazole plus 
amoxicillin, since it is a valuable adjunct to mechanical ther-
apy especially in Aggregatibacter actinomycetemcomitans 
associated periodontal infections [42-44]. Moreover a syner-
gistic interaction between both antiobiotics were reported 
[45] and using this combination as an intracanal medicament 
could have a great potential in eliminating particularly the 
periodontal pathogens. Up to the present, especially perio-
endo lesions have a poor long-term prognosis due to the 
complexity of the inflammation. TVM might be used in 
these situations as a viscous paste as an intracanal medica-
ment applied with a lentulo or syringe prior to a conventional 
intracanal dressing material or final root canal filling for up 
to 21 days. 
The use of antibiotic combinations as treatment regime 
could help the dental practitioner to give such hopeless teeth 
a better prognosis. But more research on this topic is still 
needed.  
CONCLUSION 
Within the limits and considerations of this in vitro study, 
the triple antibiotic mixture TreVitaMix as intracanal me-
dicament showed the potential to penetrate through human 
dentine and inhibit bacterial growth of Fusobacterium nu-
cleatum for prolonged periods. Therefore the medicament 
might have the potential to disinfect the inner as well as the 
outer root surface and could be an option in treating perio-
endo lesion. Nevertheless more reserach on this topic is 
needed. 
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